We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Invitrogen Launches Animal Origin Free Substrate for Stem Cells
Product News

Invitrogen Launches Animal Origin Free Substrate for Stem Cells

Invitrogen Launches Animal Origin Free Substrate for Stem Cells
Product News

Invitrogen Launches Animal Origin Free Substrate for Stem Cells


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Invitrogen Launches Animal Origin Free Substrate for Stem Cells"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Invitrogen Corporation has announced the launch of CELLstart™, the first fully defined, completely animal origin free substrate in the marketplace for the attachment and expansion of embryonic, mesenchymal and neural stem cells. CELLstart™ provides the serum-free and feeder-free scaffold upon which stem cells grow in both research and therapy applications.

“Most substrates today are either of animal origin, are highly variable, or do not support stem cell growth. Researchers need a substrate to provide consistent culture performance, lot to lot, in their move towards using animal origin free products,” said Joydeep Goswami, vice president, stem cells and regenerative medicine.

“Using CELLstart™, we have grown stem cells in an undifferentiated state, in a serum-free, feeder-free environment over multiple passages,” he added.

According to Invitrogen, CELLstart™ maintains the stem cell characteristics and differentiation capability of human embryonic stem cells, mesenchymal and neural stem cells. CELLstart™ requires researchers to go through minimal or no changes in processes from current culture methods.

Advertisement